Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cystic fibrosis prenatal genetic screening for high-risk populations recommended by NIH working groups.

This article was originally published in The Gray Sheet

Executive Summary

CYSTIC FIBROSIS PRENATAL GENETIC SCREENING FOR HIGH-RISK GROUPS ONLY is recommended by two National Institutes of Health working groups at an Oct. 15-16 workshop in Bethesda. Summarizing recommendations from the National Human Genome Research Institute-sponsored workshop, University of California at Los Angeles School of Medicine's Nancy Press, PhD, said on Oct. 16 that CF carrier screening should "not be offered to all populations, but rather to populations who are at high risk."
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009007

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel